VU661013

VU661013

Catalog Number:
L002369727APE
Mfr. No.:
APE-A8783
Price:
$1,091
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          VU661013 is a novel, potent, selective MCL-1 inhibitor (Ki of 97 ± 30 pM).[1]
          MCL-1, an anti-apoptotic BCL-2 family member, is commonly upregulated in acute myeloblastic leukemia (AML) cells. Targeting anti-apoptotic proteins in AML is a key therapeutic strategy, and MCL-1 is a critical anti-apoptotic oncoprotein. [1]
          VU661013 reduced expansion of multiple AML cell lines in vitro. Venetoclax (a BCL-2 inhibitor) and VU661013 exhibited favorable synergy in several of AML cells lines, venetoclax-resistant AML cells were sensitive to VU661013. [1]
          VU661013 decreased tumor growth in an in vivo murine model. VU661013 (25mg/kg) and venetoclax (15mg/kg) can be synergistic in patient-derived xenograft transplantation models. [1]

      • Properties
        • Alternative Name
          3-((4R)-7-chloro-10-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-4-methyl-1-oxo-6-(1,3,5-trimethyl-1H-pyrazol-4-yl)-3,4-dihydropyrazino[1,2-a]indol-2(1H)-yl)-1-methyl-1H-indole-5-carboxylic acid
          CAS Number
          2131184-57-9
          Molecular Formula
          C39H39Cl2N5O4
          Molecular Weight
          712.66
          Purity
          98.00%
          Solubility
          ≥125mg/mL in DMSO;insoluble in H2O
          Storage
          Store at -20°C

          * For Research Use Only

    We Also Recommend

    HBC

    $960

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.